What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney and salivary gland uptake.
Theranostics
; 12(14): 6179-6188, 2022.
Article
in En
| MEDLINE
| ID: mdl-36168623
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Glutamate Carboxypeptidase II
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Theranostics
Year:
2022
Document type:
Article
Affiliation country:
Canada